Form 4: Myriad Genetics Chief Accounting Officer Reports Stock Transactions
SEC Form 4 Filing
Natalie Munk, Chief Accounting Officer of Myriad Genetics, reports the disposal of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On March 22 and 24, 2024, Natalie Munk, the Chief Accounting Officer of Myriad Genetics, disposed of common stock to cover tax withholding obligations.
- A total of 363 shares were disposed of on March 22, 2024, and 981 shares were disposed of on March 24, 2024, both at a price of $22.24 per share.
- These transactions were related to the vesting of restricted stock units and performance-based restricted stock units.
- Following these transactions, Munk directly owns 45,384 shares of Myriad Genetics common stock.
Sentiment
Score: 5
Explanation: This is a routine filing related to tax obligations, so it doesn't indicate particularly positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for reporting transactions by company insiders and are publicly available to ensure transparency in the market.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they are related to tax obligations and do not represent a significant change in ownership.
Key Dates
| Date | Description |
|---|---|
| 03/22/2024 | Date of first reported transaction: Disposal of 363 shares for tax withholding. |
| 03/24/2024 | Date of second reported transaction: Disposal of 981 shares for tax withholding. |
| 03/25/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.